With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation

Neimeth International Pharmaceuticals Plc emerged as the fastest-growing listed pharmaceutical company by revenue in the first half of 2026, recording a...

Read full coverage on TraceNews